$HCWB
HCW Biologics Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022022697 Filed on November 07, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $1.342M $1.800M $0.00
YoY Change
Cost Of Revenue $1.073M $1.447M $0.00
YoY Change
Gross Profit $268.3K $361.8K $0.00
YoY Change
Gross Profit Margin 20.0% 20.1%
Selling, General & Admin $2.752M $1.701M $1.360M
YoY Change 73.79% 25.05% 145.85%
% of Gross Profit 1025.55% 470.07%
Research & Development $2.930M $2.649M $2.687M
YoY Change 97.53% -1.43% 28.05%
% of Gross Profit 1092.06% 732.11%
Depreciation & Amortization $261.2K $164.3K $124.1K
YoY Change 173.2% 32.41% -1.67%
% of Gross Profit 97.34% 45.42%
Operating Expenses $5.936M $4.381M $4.092M
YoY Change 90.7% 7.07% 51.08%
Operating Profit -$5.667M -$4.020M -$4.092M
YoY Change -1.77% 51.08%
Interest Expense -$56.24K $105.5K -$2.540K
YoY Change -7.65% -4251.97% 586.49%
% of Operating Profit
Other Income/Expense, Net $304.7K
YoY Change
Pretax Income -$5.419M -$3.914M -$4.095M
YoY Change 70.75% -4.41% 51.15%
Income Tax
% Of Pretax Income
Net Earnings -$5.419M -$3.914M -$4.095M
YoY Change 70.75% -4.41% 51.15%
Net Earnings / Revenue -403.93% -217.46%
Basic Earnings Per Share -$0.11 -$0.14
Diluted Earnings Per Share -$0.15 -$0.11 -$114.6K
COMMON SHARES
Basic Shares Outstanding 35.87M 35.83M 29.57M
Diluted Shares Outstanding 35.84M 29.57M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.06M $26.22M $40.11M
YoY Change -12.67% -34.63%
Cash & Equivalents $22.30M $26.20M $15.10M
Short-Term Investments $9.736M $0.00 $24.99M
Other Short-Term Assets $196.0K $205.9K $1.383M
YoY Change -86.36% -85.12%
Inventory
Prepaid Expenses $1.395M $1.922M $1.991M
Receivables $417.7K $355.6K $70.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $34.07M $28.71M $43.56M
YoY Change -15.83% -34.09%
LONG-TERM ASSETS
Property, Plant & Equipment $10.80M $10.96M $1.269M
YoY Change 865.48% 763.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.600M $11.27M $11.58M
YoY Change -86.12% -2.67%
Other Assets $333.9K $419.0K
YoY Change -15.11%
Total Long-Term Assets $12.74M $22.65M $12.85M
YoY Change -2.27% 76.27%
TOTAL ASSETS
Total Short-Term Assets $34.07M $28.71M $43.56M
Total Long-Term Assets $12.74M $22.65M $12.85M
Total Assets $46.81M $51.35M $56.41M
YoY Change -12.53% -8.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.226M $1.410M $637.2K
YoY Change 448.21% 121.34%
Accrued Expenses $1.730M $882.8K $1.757M
YoY Change -17.52% -49.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $38.27M
YoY Change
Total Short-Term Liabilities $2.956M $2.293M $2.395M
YoY Change 27.35% -4.23%
LONG-TERM LIABILITIES
Long-Term Debt $6.410M $6.448M $0.00
YoY Change
Other Long-Term Liabilities $14.28K $56.68K
YoY Change
Total Long-Term Liabilities $6.424M $6.505M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.956M $2.293M $2.395M
Total Long-Term Liabilities $6.424M $6.505M $0.00
Total Liabilities $9.381M $8.798M $2.395M
YoY Change 304.06% 267.42%
SHAREHOLDERS EQUITY
Retained Earnings -$45.54M -$40.12M -$27.46M
YoY Change 48.64% 46.08%
Common Stock $3.588K $3.584K
YoY Change 0.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $37.43M $42.56M $54.01M
YoY Change
Total Liabilities & Shareholders Equity $46.81M $51.35M $56.41M
YoY Change -12.53% -8.96%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$5.419M -$3.914M -$4.095M
YoY Change 70.75% -4.41% 51.15%
Depreciation, Depletion And Amortization $261.2K $164.3K $124.1K
YoY Change 173.2% 32.41% -1.67%
Cash From Operating Activities -$3.789M -$2.315M -$5.119M
YoY Change 12.22% -54.78% 86.17%
INVESTING ACTIVITIES
Capital Expenditures $68.69K -$10.17M -$4.130K
YoY Change -446.05% 246146.49% -96.07%
Acquisitions
YoY Change
Other Investing Activities $0.00 $16.98M -$34.97M
YoY Change -100.0% -148.57%
Cash From Investing Activities -$68.69K $6.814M -$34.97M
YoY Change 187.29% -119.48% 33139.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -39.84K 6.305M 50.16M
YoY Change -752.05% -87.43% 713.16%
NET CHANGE
Cash From Operating Activities -3.789M -2.315M -5.119M
Cash From Investing Activities -68.69K 6.814M -34.97M
Cash From Financing Activities -39.84K 6.305M 50.16M
Net Change In Cash -3.898M 10.80M 10.07M
YoY Change 14.83% 7.24% 203.95%
FREE CASH FLOW
Cash From Operating Activities -$3.789M -$2.315M -$5.119M
Capital Expenditures $68.69K -$10.17M -$4.130K
Free Cash Flow -$3.858M $7.855M -$5.115M
YoY Change 14.93% -253.58% 93.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Gross Profit
GrossProfit
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
hcwb Forfeiture Of Cumulative Dividends
ForfeitureOfCumulativeDividends
0
hcwb Issuance Costs Of Initial Public Offering
IssuanceCostsOfInitialPublicOffering
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
0
dei Entity Central Index Key
EntityCentralIndexKey
0001828673
us-gaap Cost Of Revenue
CostOfRevenue
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0
dei Amendment Flag
AmendmentFlag
false
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4094704
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33025
dei City Area Code
CityAreaCode
954
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-5024477
dei Entity Address Address Line1
EntityAddressAddressLine1
2929 N
dei Entity Address Address Line2
EntityAddressAddressLine2
Commerce Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Miramar
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40591
dei Entity Registrant Name
EntityRegistrantName
HCW Biologics Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Local Phone Number
LocalPhoneNumber
842–2024
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
HCWB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35871470
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11730677
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26224260
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
24983520
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
0
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
133000
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
355555
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2196557
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1921993
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1436616
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
205921
CY2021Q4 us-gaap Assets Current
AssetsCurrent
40480370
CY2022Q3 us-gaap Assets Current
AssetsCurrent
28707729
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
11522050
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
11268500
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1119091
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10957946
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
393318
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
419027
CY2021Q4 us-gaap Assets
Assets
53514829
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1410357
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2097925
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
882775
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2321589
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2293132
CY2022Q3 us-gaap Assets
Assets
51353202
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
223664
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
0
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
6448166
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
0
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
56676
CY2021Q4 us-gaap Liabilities
Liabilities
2321589
CY2022Q3 us-gaap Liabilities
Liabilities
8797974
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35768264
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35836135
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3577
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
3584
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
81827006
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82670949
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30637343
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40119305
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
51193240
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
42555228
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53514829
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51353202
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1809025
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5380570
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
0
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1447220
us-gaap Cost Of Revenue
CostOfRevenue
3062496
CY2021Q3 us-gaap Gross Profit
GrossProfit
0
CY2022Q3 us-gaap Gross Profit
GrossProfit
361805
us-gaap Gross Profit
GrossProfit
2318074
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2687341
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2648794
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6690317
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6408353
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1404823
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1732666
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3565013
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5321262
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
4092164
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
4381460
us-gaap Operating Expenses
OperatingExpenses
10255330
us-gaap Operating Expenses
OperatingExpenses
11729615
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4092164
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4019655
us-gaap Operating Income Loss
OperatingIncomeLoss
-10255330
us-gaap Operating Income Loss
OperatingIncomeLoss
-9411541
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2540
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
105461
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
566268
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-70421
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
42555228
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3914194
us-gaap Net Income Loss
NetIncomeLoss
-9689062
us-gaap Net Income Loss
NetIncomeLoss
-9481962
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29572267
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29572267
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35835135
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35835135
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13111087
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13111087
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35809216
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35809216
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-16718397
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13385
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
641
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
477358
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2843996
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-20025725
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9465
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9578
CY2021Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
482658
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2750362
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-23239702
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
576
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1660
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4094704
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
54011448
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
51193240
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2273
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
260348
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2057207
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
49398654
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
271335
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3510561
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
46165428
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1674
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
302320
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3914194
us-gaap Net Income Loss
NetIncomeLoss
-9689062
us-gaap Net Income Loss
NetIncomeLoss
-9481962
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
436135
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
456696
us-gaap Share Based Compensation
ShareBasedCompensation
11878
us-gaap Share Based Compensation
ShareBasedCompensation
834003
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
567311
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
253550
hcwb Reduction In The Carrying Amount Of Right Of Use Asset
ReductionInTheCarryingAmountOfRightOfUseAsset
0
hcwb Reduction In The Carrying Amount Of Right Of Use Asset
ReductionInTheCarryingAmountOfRightOfUseAsset
1463
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2430000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
222555
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2181492
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1854155
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1960729
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-202979
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-89110
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7599123
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6596739
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27411
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10206441
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
24983520
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
24989700
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
9977900
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34995011
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14777079
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
56000000
hcwb Issuance Costs Of Initial Public Offering
IssuanceCostsOfInitialPublicOffering
6760053
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23426
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9947
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
6448166
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
144870
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-49263373
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6313243
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6669239
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14493583
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8455834
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11730677
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15125073
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26224260
hcwb Cumulative Dividends Earned And Accrued In The Reporting Period
CumulativeDividendsEarnedAndAccruedInTheReportingPeriod
100776
hcwb Cumulative Dividends Earned And Accrued In The Reporting Period
CumulativeDividendsEarnedAndAccruedInTheReportingPeriod
0
hcwb Forfeiture Of Cumulative Dividends
ForfeitureOfCumulativeDividends
2822081
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
567311
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
0
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
231196
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26200000
hcwb Cumulative Losses To Conduct Product Research And Development In Future
CumulativeLossesToConductProductResearchAndDevelopmentInFuture
37300000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1800000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5400000
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:13.5pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred Revenue</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:10.2%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue represents amounts billed, or in certain cases yet to be billed, to the Company’s customer for which the related revenues have not been recognized because one or more of the revenue recognition criteria has not been met. The Company had deferred revenue of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and nil as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021 and September 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively. All deferred revenue balances are current liabilities and reported within Accrued liabilities and other current liabilities in the accompanying condensed balance sheets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2100000
CY2021 us-gaap Other General Expense
OtherGeneralExpense
50000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
882775
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
174520
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4094704
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3914194
us-gaap Net Income Loss
NetIncomeLoss
-9689062
us-gaap Net Income Loss
NetIncomeLoss
-9481962
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29572267
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29572267
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35835135
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35835135
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13111087
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13111087
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35809216
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35809216
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1710817
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1907991
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
44412319
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
34456307
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2022Q3 us-gaap Area Of Land
AreaOfLand
12250
CY2022Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P2Y
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2024-02-29
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
42413
us-gaap Operating Lease Cost
OperatingLeaseCost
84825
us-gaap Operating Lease Payments
OperatingLeasePayments
111429
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
89110
hcwb Supplemental Balance Sheet Operating Leases Disclosure Table Textblock
SupplementalBalanceSheetOperatingLeasesDisclosureTableTextblock
<p style="text-indent:10.2%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 30, 2022, the supplemental balance sheet information related to leases was as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:79.469%;"/> <td style="width:1.936%;"/> <td style="width:1.0%;"/> <td style="width:16.594%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of September 30, 2022</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(204,238,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">229,733</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other current liabilities</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">174,520</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(204,238,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56,676</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating lease liabilities</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">231,196</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> </tr> </table>
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
229733
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
174520
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56676
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
231196
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
41786
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
171322
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
28693
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
241801
CY2021Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
36300
CY2022Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
43700
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
104100
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
130300
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
2.5
CY2022Q3 us-gaap Contractual Obligation
ContractualObligation
2.0

Files In Submission

Name View Source Status
0000950170-22-022697-index-headers.html Edgar Link pending
0000950170-22-022697-index.html Edgar Link pending
0000950170-22-022697.txt Edgar Link pending
0000950170-22-022697-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hcwb-20220930.htm Edgar Link pending
hcwb-20220930.xsd Edgar Link pending
hcwb-ex10_1.htm Edgar Link pending
hcwb-ex10_2.htm Edgar Link pending
hcwb-ex31_1.htm Edgar Link pending
hcwb-ex31_2.htm Edgar Link pending
hcwb-ex32_1.htm Edgar Link pending
hcwb-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hcwb-20220930_cal.xml Edgar Link unprocessable
hcwb-20220930_def.xml Edgar Link unprocessable
hcwb-20220930_lab.xml Edgar Link unprocessable
hcwb-20220930_pre.xml Edgar Link unprocessable
hcwb-20220930_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending